Coverage
-
May 31, 2013
A Shire PLC unit said Friday that it had reached a settlement with Teva Pharmaceuticals USA Inc. resolving allegations that Teva infringed two patents for the attention deficit hyperactivity disorder drug Intuniv.
1 other articles on this case.
View all »